Malik Fady Ibraham bought CYTK

April 7, 2026 · Form 4 insider transaction

Malik Fady Ibraham bought 1,000 shares of Cytokinetics, Incorporated at $10.60 per share, a transaction worth $10.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.